Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,311 | 93 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie Inc. | $367.05 | 18 | $0 (2023) |
| Novo Nordisk Inc | $327.95 | 7 | $0 (2024) |
| PFIZER INC. | $327.56 | 16 | $0 (2021) |
| SANOFI-AVENTIS U.S. LLC | $288.87 | 4 | $0 (2019) |
| Amgen Inc. | $214.89 | 11 | $0 (2023) |
| Lilly USA, LLC | $136.18 | 7 | $0 (2024) |
| Janssen Biotech, Inc. | $120.69 | 5 | $0 (2022) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $76.61 | 4 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $74.72 | 3 | $0 (2023) |
| Abbott Laboratories | $60.09 | 3 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $91.79 | 5 | Novo Nordisk Inc ($38.29) |
| 2023 | $272.34 | 13 | AbbVie Inc. ($98.98) |
| 2022 | $588.29 | 27 | ABBVIE INC. ($154.74) |
| 2021 | $435.96 | 17 | Novo Nordisk Inc ($152.66) |
| 2020 | $135.45 | 7 | PFIZER INC. ($113.83) |
| 2019 | $325.57 | 10 | PFIZER INC. ($142.88) |
| 2018 | $331.04 | 7 | SANOFI-AVENTIS U.S. LLC ($267.27) |
| 2017 | $130.14 | 7 | Amgen Inc. ($38.86) |
All Payment Transactions
93 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/21/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: Diabetes | ||||||
| 08/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.28 | General |
| Category: Diabetes | ||||||
| 03/28/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: Obesity | ||||||
| 03/06/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: Immunology | ||||||
| 01/05/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: Gastroenterology | ||||||
| 12/21/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: Diabetes | ||||||
| 12/14/2023 | AbbVie Inc. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $26.94 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2023 | MannKind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: DIABETES MEDICINE | ||||||
| 11/29/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: Gastroenterology | ||||||
| 09/26/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $24.19 | General |
| Category: Cardio-renal | ||||||
| 08/30/2023 | AbbVie Inc. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $28.62 | General |
| Category: IMMUNOLOGY | ||||||
| 08/24/2023 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: Diabetes | ||||||
| 07/20/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: Cardiology | ||||||
| 05/10/2023 | Intra-Sana Laboratories | RELTONE 200 MG (Drug), GLYCATE, RELTONE 400 MG | Food and Beverage | In-kind items and services | $27.01 | General |
| Category: GALLSTONES | ||||||
| 05/03/2023 | AbbVie Inc. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: IMMUNOLOGY | ||||||
| 03/18/2023 | AbbVie Inc. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $24.93 | General |
| Category: ENDOCRINOLOGY | ||||||
| 03/14/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: Diabetes | ||||||
| 03/07/2023 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/08/2022 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $29.29 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/01/2022 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $3.66 | General |
| Category: IMMUNOLOGY | ||||||
| 10/26/2022 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $31.96 | General |
| Category: Immunology | ||||||
| 10/20/2022 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $28.10 | General |
| Category: IMMUNOLOGY | ||||||
| 08/30/2022 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $8.25 | General |
| Category: IMMUNOLOGY | ||||||
| 08/16/2022 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.01 | General |
| Category: Diabetes | ||||||
| 08/16/2022 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $12.66 | General |
| Category: Bone Health | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 816 | 950 | $329,839 | $75,555 |
| 2022 | 11 | 1,251 | 1,356 | $325,991 | $70,614 |
| 2021 | 18 | 2,742 | 2,986 | $430,251 | $115,673 |
| 2020 | 11 | 881 | 1,018 | $303,301 | $55,629 |
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 241 | 256 | $190,720 | $37,837 | 19.8% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 42 | 42 | $25,956 | $11,838 | 45.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 61 | 88 | $48,400 | $9,598 | 19.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 73 | 98 | $36,750 | $7,029 | 19.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 45 | 45 | $7,920 | $3,230 | 40.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 237 | 303 | $6,276 | $2,545 | 40.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 45 | 45 | $4,860 | $1,579 | 32.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 44 | 44 | $4,752 | $1,544 | 32.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 28 | 29 | $4,205 | $354.12 | 8.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 229 | 233 | $173,585 | $34,820 | 20.1% |
| 0064A | Adm sarscov2 50mcg/0.25mlbst | Office | 2022 | 218 | 219 | $37,770 | $10,087 | 26.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 55 | 69 | $37,950 | $7,556 | 19.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 77 | 95 | $35,625 | $6,915 | 19.4% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 16 | 16 | $9,888 | $4,466 | 45.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 40 | 40 | $7,040 | $2,742 | 38.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 42 | 42 | $4,536 | $1,452 | 32.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 264 | 328 | $6,560 | $971.31 | 14.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 72 | 75 | $10,875 | $908.38 | 8.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 20 | 20 | $2,160 | $695.48 | 32.2% |
| 91306 | Sarscov2 vac 50mcg/0.25ml im | Office | 2022 | 218 | 219 | $2.19 | $2.19 | 100.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 201 | 202 | $150,490 | $29,015 | 19.3% |
| 0002A | Adm sarscov2 30mcg/0.3ml 2nd | Office | 2021 | 597 | 598 | $52,595 | $23,233 | 44.2% |
| 0001A | Adm sarscov2 30mcg/0.3ml 1st | Office | 2021 | 594 | 697 | $36,768 | $15,863 | 43.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 75 | 101 | $55,550 | $11,173 | 20.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 99 | 130 | $48,750 | $9,698 | 19.9% |
About Dr. Caren Behar, MD
Dr. Caren Behar, MD is a Internal Medicine healthcare provider based in White Plains, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1124048780.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Caren Behar, MD has received a total of $2,311 in payments from pharmaceutical and medical device companies, with $91.79 received in 2024. These payments were reported across 93 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($2,311).
As a Medicare-enrolled provider, Behar has provided services to 5,690 Medicare beneficiaries, totaling 6,310 services with total Medicare billing of $317,471. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location White Plains, NY
- Active Since 07/19/2006
- Last Updated 02/23/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1124048780
Products in Payments
- SYNTHROID (Drug) $289.80
- Ozempic (Drug) $185.81
- CHANTIX (Drug) $185.45
- PRALUENT (Drug) $163.87
- Repatha (Biological) $163.37
- ELIQUIS (Drug) $142.11
- MULTAQ (Drug) $125.00
- Saxenda (Drug) $121.15
- TREMFYA (Drug) $120.69
- XIFAXAN (Drug) $76.61
- Kerendia (Drug) $74.72
- UNITHROID (Drug) $48.89
- Corlanor (Drug) $38.86
- MOUNJARO (Drug) $38.19
- JARDIANCE (Drug) $37.96
- Synthroid (Drug) $32.37
- Omnipod (Device) $30.53
- RELTONE 200 MG (Drug) $27.01
- TRULICITY (Drug) $26.20
- ILUMYA (Biological) $25.44
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in White Plains
Tomrul Tuzel, M.d, M.D
Internal Medicine — Payments: $113,652
Dr. Sharon Parish, Md, MD
Internal Medicine — Payments: $74,824
Despoina Michailidou, Md, MD
Internal Medicine — Payments: $73,621
Daniel Wang, M.d, M.D
Internal Medicine — Payments: $19,656
Dr. Breta Boots, Do, DO
Internal Medicine — Payments: $9,255
Dr. Vivian Volterre, M.d, M.D
Internal Medicine — Payments: $7,003